StrataGent Life Sciences
	Developer of painless and non-invasive versions of therapies. The company offers large and small therapeutic molecules without a device penetrating into or through the skin.
	['', 'drug therapy', ' ', 'painless therapy', ' ', 'non-evasive therapy', ' ', 'drug delivery', '']
InnoPharma
	Developer of complex generic and innovative specialty pharmaceutical/bio-pharmaceutical products in injectable and ophthalmic dosage forms. The company has a broad portfolio of products under development, with formulations including, suspension, lyophilized, emulsions, liposomes, micelles and lipid complexes.
	['', 'medical product', ' ', 'drug development', ' ', 'bio pharmaceutical product', ' ', 'medical drug research', ' ', 'sterile injectable product', ' ', 'sterile products', ' injectable ophthalmic']
On Demand Therapeutics
	Developer of a drug-delivery implant to treat retinal diseases. The company creates relationships with pharmaceutical and medical-device companies to develop ophthalmic products based on the device.
	['', 'retinal disease treatment', ' ', 'ophthalmic therapy', ' ', 'drug delivery', '']
Salient Interventions
	Developer of drug for neurologic diseases. The company develops products focused on early treatment of neurologic diseases and reversal of neurologic deficits.
	['neurologic ', 'neurologic deficits.', '']
Pixium Vision
	Developer of technology to treat blindness. The company is the developer of IRIS retinal implant system, designed to replace the function of photoreceptors in the retina which are damaged by retinal dystrophy and macular degeneration.
	['', 'retinal dystrophy', ' ', 'data processing', ' electrode ', 'retina blindness', ' ', 'retinal implant', '']
